Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

Virology

Volumn 340, Issue 2, 2005, Pages 174-182

  Kapadia, Sagar U ^a   Rose, John K ^a   Lamirande, Elaine ^b   Vogel, Leatrice ^b   Subbarao, Kanta ^b   Roberts, Anjeanette ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Intranasal; Neutralizing antibodies; Protective immunity; Spike

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SPIKE PROTEIN; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS VACCINE; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; GOLGI COMPLEX; LONG TERM CARE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; CELL LINE; CRICETINAE; DNA PRIMERS; IMMUNITY, CELLULAR; KIDNEY; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINES, ATTENUATED; VACCINES, DNA; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL VACCINES;

ANIMALIA; CORONAVIRUS; SARS CORONAVIRUS; SARS COV; VESICULAR STOMATITIS VIRUS;

EID: 24944432298     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.06.016     Document Type: Article

References (42)

1. H. Bisht, A. Roberts, L. Vogel, A. Bukreyev, P.L. Collins, B.R. Murphy, K. Subbarao, and B. Moss Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Proc. Natl. Acad. Sci. U.S.A. 101 17 2004 6641 6646
2. B.J. Bosch, B.E. Martina, R. Van Der Zee, J. Lepault, B.J. Haijema, C. Versluis, A.J. Heck, R. De Groot, A.D. Osterhaus, and P.J. Rottier Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides Proc. Natl. Acad. Sci. U.S.A. 101 22 2004 8455 8460
3. A. Bukreyev, E.W. Lamirande, U.J. Buchholz, L.N. Vogel, W.R. Elkins, M. St Claire, B.R. Murphy, K. Subbarao, and P.L. Collins Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS Lancet 363 9427 2004 2122 2127
4. Z. Chen, L. Zhang, C. Qin, L. Ba, C.E. Yi, F. Zhang, Q. Wei, T. He, W. Yu, J. Yu, H. Gao, X. Tu, A. Gettie, M. Farzan, K.Y. Yuen, and D.D. Ho Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region J. Virol. 79 5 2005 2678 2688
5. S. Crotty, P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed Cutting edge: long-term B cell memory in humans after smallpox vaccination J. Immunol. 171 10 2003 4969 4973
6. M. Czub, H. Weingartl, S. Czub, R. He, and J. Cao Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets Vaccine 23 17-18 2005 2273 2279
7. M. De Diego, M.D. Laviada, L. Enjuanes, and J.M. Escribano Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus J. Virol. 66 11 1992 6502 6508
8. C. Drosten, S. Gunther, W. Preiser, S. van der Werf, H.R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R.A. Fouchier, A. Berger, A.M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J.C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H.D. Klenk, A.D. Osterhaus, H. Schmitz, and H.W. Doerr Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med. 348 20 2003 1967 1976
9. M.A. Egan, S.Y. Chong, N.F. Rose, S. Megati, K.J. Lopez, E.B. Schadeck, J.E. Johnson, A. Masood, P. Piacente, R.E. Druilhet, P.W. Barras, D.L. Hasselschwert, P. Reilly, E.M. Mishkin, D.C. Montefiori, M.G. Lewis, D.K. Clarke, R.M. Hendry, P.A. Marx, J.H. Eldridge, S.A. Udem, Z.R. Israel, and J.K. Rose Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes AIDS Res. Hum. Retroviruses 20 9 2004 989 1004
10. T.R. Fuerst, E.G. Niles, F.W. Studier, and B. Moss Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase Proc. Natl. Acad. Sci. U.S.A. 83 21 1986 8122 8126
11. W. Gao, A. Tamin, A. Soloff, L. D'Aiuto, E. Nwanegbo, P.D. Robbins, W.J. Bellini, S. Barratt-Boyes, and A. Gambotto Effects of a SARS-associated coronavirus vaccine in monkeys Lancet 362 9399 2003 1895 1896
12. Y. Guan, B.J. Zheng, Y.Q. He, X.L. Liu, Z.X. Zhuang, C.L. Cheung, S.W. Luo, P.H. Li, L.J. Zhang, Y.J. Guan, K.M. Butt, K.L. Wong, K.W. Chan, W. Lim, K.F. Shortridge, K.Y. Yuen, J.S. Peiris, and L.L. Poon Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 5643 2003 276 278
13. Y. He, Y. Zhou, P. Siddiqui, and S. Jiang Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry Biochem. Biophys. Res. Commun. 325 2 2004 445 452
14. J. Ignjatovic, and L. Galli The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens Arch. Virol. 138 1-2 1994 117 134
15. S.A. Jeffers, S.M. Tusell, L. Gillim-Ross, E.M. Hemmila, J.E. Achenbach, G.J. Babcock, W.D. Thomas Jr., L.B. Thackray, M.D. Young, R.J. Mason, D.M. Ambrosino, D.E. Wentworth, J.C. Demartini, and K.V. Holmes CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus Proc. Natl. Acad. Sci. U.S.A. 101 44 2004 15748 15753
16. J.S. Kahn, A. Roberts, C. Weibel, L. Buonocore, and J.K. Rose Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge J. Virol. 75 22 2001 11079 11087
17. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, and L.J. Anderson A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 20 2003 1953 1966
18. N.D. Lawson, E.A. Stillman, M.A. Whitt, and J.K. Rose Recombinant vesicular stomatitis viruses from DNA Proc. Natl. Acad. Sci. U.S.A. 92 10 1995 4477 4481
19. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H. Choe, and M. Farzan Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 6965 2003 450 454
20. S. Liu, G. Xiao, Y. Chen, Y. He, J. Niu, C.R. Escalante, H. Xiong, J. Farmar, A.K. Debnath, P. Tien, and S. Jiang Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors Lancet 363 9413 2004 938 947
21. M.A. Marra, S.J. Jones, C.R. Astell, R.A. Holt, A. Brooks-Wilson, Y.S. Butterfield, J. Khattra, J.K. Asano, S.A. Barber, S.Y. Chan, A. Cloutier, S.M. Coughlin, D. Freeman, N. Girn, O.L. Griffith, S.R. Leach, M. Mayo, H. McDonald, S.B. Montgomery, P.K. Pandoh, A.S. Petrescu, A.G. Robertson, J.E. Schein, A. Siddiqui, D.E. Smailus, J.M. Stott, G.S. Yang, F. Plummer, A. Andonov, H. Artsob, N. Bastien, K. Bernard, T.F. Booth, D. Bowness, M. Czub, M. Drebot, L. Fernando, R. Flick, M. Garbutt, M. Gray, A. Grolla, S. Jones, H. Feldmann, A. Meyers, A. Kabani, Y. Li, S. Normand, U. Stroher, G.A. Tipples, S. Tyler, R. Vogrig, D. Ward, B. Watson, R.C. Brunham, M. Krajden, M. Petric, D.M. Skowronski, C. Upton, and R.L. Roper The Genome sequence of the SARS-associated coronavirus Science 300 5624 2003 1399 1404
22. J.S. Peiris, Y. Guan, and K.Y. Yuen Severe acute respiratory syndrome Nat. Med. 10 12 Suppl 2004 S88 S97
23. M. Pope, S.W. Chung, T. Mosmann, J.L. Leibowitz, R.M. Gorczynski, and G.A. Levy Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection J. Immunol. 156 9 1996 3342 3349
24. D. Qu, B. Zheng, X. Yao, Y. Guan, Z.H. Yuan, N.S. Zhong, L.W. Lu, J.P. Xie, and Y.M. Wen Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice Vaccine 23 7 2005 924 931
25. A. Roberts, E. Kretzschmar, A.S. Perkins, J. Forman, R. Price, L. Buonocore, Y. Kawaoka, and J.K. Rose Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge J. Virol. 72 6 1998 4704 4711
26. A. Roberts, L. Buonocore, R. Price, J. Forman, and J.K. Rose Attenuated vesicular stomatitis viruses as vaccine vectors J. Virol. 73 5 1999 3723 3732
27. A. Roberts, J.D. Reuter, J.H. Wilson, S. Baldwin, and J.K. Rose Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein J. Virol. 78 6 2004 3196 3199
28. J.K. Rose, and M.A. Whitt Rhabdoviridae: the viruses and their replication D.M. Knipe P.M. Howley D.E. Griffin R.A. Lamb M.A. Martin B. Roizman S.E. Straus Fields' Virology 4th ed. 2001 Lippincott Williams and Wilkins Philadelphia
29. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, S.M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, and J.K. Rose An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 106 5 2001 539 549
30. P.A. Rota, M.S. Oberste, S.S. Monroe, W.A. Nix, R. Campagnoli, J.P. Icenogle, S. Penaranda, B. Bankamp, K. Maher, M.H. Chen, S. Tong, A. Tamin, L. Lowe, M. Frace, J.L. DeRisi, Q. Chen, D. Wang, D.D. Erdman, T.C. Peret, C. Burns, T.G. Ksiazek, P.E. Rollin, A. Sanchez, S. Liffick, B. Holloway, J. Limor, K. McCaustland, M. Olsen-Rasmussen, R. Fouchier, S. Gunther, A.D. Osterhaus, C. Drosten, M.A. Pallansch, L.J. Anderson, and W.J. Bellini Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 5624 2003 1394 1399
31. B. Schlereth, J.K. Rose, L. Buonocore, V. ter Meulen, and S. Niewiesk Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies J. Virol. 74 10 2000 4652 4657
32. M.J. Schnell, L. Buonocore, M.A. Whitt, and J.K. Rose The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus J. Virol. 70 4 1996 2318 2323
33. K. Subbarao, J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W.J. Shieh, S. Zaki, and B. Murphy Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice J. Virol. 78 7 2004 3572 3577
34. N. Takasuka, H. Fujii, Y. Takahashi, M. Kasai, S. Morikawa, S. Itamura, K. Ishii, M. Sakaguchi, K. Ohnishi, M. Ohshima, S. Hashimoto, T. Odagiri, M. Tashiro, H. Yoshikura, T. Takemori, and Y. Tsunetsugu-Yokota A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice Int. Immunol. 16 10 2004 1423 1430
35. L. Tang, Q. Zhu, E. Qin, M. Yu, Z. Ding, H. Shi, X. Cheng, C. Wang, G. Chang, F. Fang, H. Chang, S. Li, X. Zhang, X. Chen, J. Yu, J. Wang, and Z. Chen Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice DNA Cell Biol. 23 6 2004 391 394
36. H. Vennema, R.J. de Groot, D.A. Harbour, M. Dalderup, T. Gruffydd-Jones, M.C. Horzinek, and W.J. Spaan Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization J. Virol. 64 3 1990 1407 1409
37. H. Weingartl, M. Czub, S. Czub, J. Neufeld, P. Marszal, J. Gren, G. Smith, S. Jones, R. Proulx, Y. Deschambault, E. Grudeski, A. Andonov, R. He, Y. Li, J. Copps, A. Grolla, D. Dick, J. Berry, S. Ganske, L. Manning, and J. Cao Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets J. Virol. 78 22 2004 12672 12676
38. J.G. Wesseling, G.J. Godeke, V.E. Schijns, L. Prevec, F.L. Graham, M.C. Horzinek, and P.J. Rottier Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection J. Gen. Virol. 74 Pt. 10 1993 2061 2069
39. S. Xiong, Y.F. Wang, M.Y. Zhang, X.J. Liu, C.H. Zhang, S.S. Liu, C.W. Qian, J.X. Li, J.H. Lu, Z.Y. Wan, H.Y. Zheng, X.G. Yan, M.J. Meng, and J.L. Fan Immunogenicity of SARS inactivated vaccine in BALB/c mice Immunol. Lett. 95 2 2004 139 143
40. Z.Y. Yang, W.P. Kong, Y. Huang, A. Roberts, B.R. Murphy, K. Subbarao, and G.J. Nabel A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Nature 428 6982 2004 561 564
41. K. Yuan, L. Yi, J. Chen, X. Qu, T. Qing, X. Rao, P. Jiang, J. Hu, Z. Xiong, Y. Nie, X. Shi, W. Wang, C. Ling, X. Yin, K. Fan, L. Lai, M. Ding, and H. Deng Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein Biochem. Biophys. Res. Commun. 319 3 2004 746 752
42. C.H. Zhang, Z.M. Guo, H.Y. Zheng, J.H. Lu, Y.F. Wang, X.G. Yan, Y. Zhao, X.W. Du, X. Zhang, L. Fang, W.H. Ling, S.Y. Qi, X.B. Yu, and N.S. Zhong Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain Chin. Med. J. (Engl) 117 11 2004 1625 1629